On May 19, 2023, Cytek Biosciences Inc. (NASDAQ: CTKB) opened at $6.88, higher 5.08% from the last session. During the day, the shares moved up to $7.47 and dropped to $6.82 before settling in for the closing price of $6.69. Price fluctuations for CTKB have ranged from $6.45 to $16.05 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 40.00% at the time writing. With a float of $111.55 million, this company’s outstanding shares have now reached $135.49 million.
The firm has a total of 682 workers. Let’s measure their productivity. In terms of profitability, gross margin is +61.92, operating margin of -0.73, and the pretax margin is +0.77.
Cytek Biosciences Inc. (CTKB) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Cytek Biosciences Inc. is 11.80%, while institutional ownership is 53.10%. The most recent insider transaction that took place on May 19, was worth 143,800. In this transaction Chief Technology Officer of this company sold 20,000 shares at a rate of $7.19, taking the stock ownership to the 7,870,258 shares. Before that another transaction happened on May 08, when Company’s President and CEO sold 20,000 for $11.55, making the entire transaction worth $231,000. This insider now owns 7,664,439 shares in total.
Cytek Biosciences Inc. (CTKB) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 3/30/2023, the company posted $0 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at $0.03) by -$0.03. This company achieved a net margin of +1.57 while generating a return on equity of 0.62. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 40.00% per share during the next fiscal year.
Cytek Biosciences Inc. (NASDAQ: CTKB) Trading Performance Indicators
Check out the current performance indicators for Cytek Biosciences Inc. (CTKB). In the past quarter, the stock posted a quick ratio of 6.30. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.46.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.02, a number that is poised to hit 0.04 in the next quarter and is forecasted to reach 0.31 in one year’s time.
Technical Analysis of Cytek Biosciences Inc. (CTKB)
Analysing the last 5-days average volume posted by the [Cytek Biosciences Inc., CTKB], we can find that recorded value of 1.57 million was better than the volume posted last year of 1.12 million. As of the previous 9 days, the stock’s Stochastic %D was 6.44%. Additionally, its Average True Range was 0.68.
During the past 100 days, Cytek Biosciences Inc.’s (CTKB) raw stochastic average was set at 7.92%, which indicates a significant decrease from 9.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 118.44% in the past 14 days, which was higher than the 74.39% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.47, while its 200-day Moving Average is $11.99. Now, the first resistance to watch is $7.39. This is followed by the second major resistance level at $7.76. The third major resistance level sits at $8.04. If the price goes on to break the first support level at $6.74, it is likely to go to the next support level at $6.46. Now, if the price goes above the second support level, the third support stands at $6.09.
Cytek Biosciences Inc. (NASDAQ: CTKB) Key Stats
There are currently 135,667K shares outstanding in the company with a market cap of 907.57 million. Presently, the company’s annual sales total 164,040 K according to its annual income of 2,580 K. Last quarter, the company’s sales amounted to 37,090 K and its income totaled -6,810 K.
